Vaccine

Ovation.io and PD Theranostics (PDTx) Complete Merger Creating a Multiomic Data Company Which Owns a Unique Population-Scale Biobank of Disease-Specific Biospecimens

Ovation owns a unique population-scale biobank of consented and linkable disease-specific biospecimens, which includes more than 1.6 million samples from…

1 year ago

Lucius Partners Portfolio Company, PD Theranostics, Completes its Merger with Ovation.io Creating a Multiomic Data Company Which Owns a Unique Population-Scale Biobank of Disease-Specific Biospecimens

Ovation owns a unique population-scale biobank of consented and linkable disease-specific biospecimens, which includes more than 1.6 million samples from over…

1 year ago

IntegriChain’s Access Insights Conference to Feature Powerhouse Roster of Pharma Industry Thought Leaders

Industry Conference Focused on Overcoming Healthcare Policy, Economic, and Business Hurdles in Go-to-Market Decisioning and Net Revenue Optimization PHILADELPHIA, Sept.…

1 year ago

P95 Acquires Assign DMB, Expanding Data Management and Biostatistics Services

LEUVEN, Belgium, Sept. 5, 2024 /PRNewswire/ -- P95 BV ("P95"), a leading global provider of epidemiology and clinical solutions with a specialty…

1 year ago

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1

Moderna's updated COVID-19 mRNA vaccine will be available for the 2024-2025 vaccination season, pending a European Commission authorization decision CAMBRIDGE,…

1 year ago

Spectral AI Awarded Additional Funding from Medical Technology Enterprise Consortium to Support Ongoing Development of DeepView SnapShot M®

Project Funding Exceeds $7.0 MillionDALLAS, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the…

1 year ago

Ventis Medical Announces FDA Clearance of the VM-2000

Ventis Medical Introduces a Technologically Advanced and Affordable Ventilator That Fills an Unmet Need PRINCETON, NJ / ACCESSWIRE / September…

1 year ago

Emmes awarded multi-task, IDIQ contract with $50M ceiling, to support NIDA’s clinical trials network

Emmes, part of Emmes Group, today announced they will provide a Clinical Coordinating Center for the NIH's National Institute on…

1 year ago

Sunshine Biopharma Announces Publication of Significant Coronavirus Research Results in the Journal of Medicinal Chemistry

Current Test Positivity Rate for Coronavirus Infection in the U.S. is 18%Development of a novel antiviral compound, XR8-23 (Compound 10),…

1 year ago

Three Complete Responses in Azer-Cel Allogeneic CD19 CAR T Phase 1b Trial in Blood Cancer (Diffuse Large B-Cell Lymphoma)

10 patients have been treated to date with azer-cel in the Phase 1b diffuse large B-cell lymphoma (DLBCL) trial Cohort…

1 year ago